Loading
Pioneer of DNA methylation analysis whose Garvan laboratory studies how epigenetic changes drive prostate and breast cancer.
Susan Clark heads the Cancer Epigenetics Laboratory at the Garvan Institute of Medical Research in Sydney. She developed the bisulphite sequencing method that made genome-wide DNA methylation mapping possible, and her group investigates epigenome remodelling in prostate and breast cancer and its use in biomarkers. She is a Fellow of the Australian Academy of Science.
| Title | Journal | Year |
|---|---|---|
| DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer | Nature Communications | 2015 |
| Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value | Nature Communications | 2015 |
| Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer | Nature Communications | 2020 |
Shares Garvan Institute of Medical Research / Kinghorn Cancer Centre and the tag clinician-scientist.
Shares HR-positive / HER2-negative breast cancer and the tags clinician-scientist, breast cancer.
Shares HR-positive / HER2-negative breast cancer and the tags clinician-scientist, breast cancer.
Shares HR-positive / HER2-negative breast cancer and the tags clinician-scientist, breast cancer.
Shares Prostate cancer and the tags clinician-scientist, prostate cancer.
Shares Prostate cancer and the tags clinician-scientist, prostate cancer.
Shares HR-positive / HER2-negative breast cancer and the tags clinician-scientist, breast cancer.
Shares Prostate cancer and the tags clinician-scientist, prostate cancer.